GlassScriptPhysician profile
Benjamin M Kelley
NPI 1285059113
$3,981.57
in general payments reported to CMS, 2019-2025
21 companies · $541 in 2025
The $541 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $743 · 2020: $45.95 · 2021: $954 · 2022: $241 · 2023: $142 · 2024: $1,315 · 2025: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,655 · Travel and Lodging: $339 · Gift: $3.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,654.51 |
| Travel and Lodging | $339.37 |
| Gift | $3.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,390.67 | 2019-2025 | Xpress Loprofile |
| Acclarent, INC | $530.53 | 2022-2024 | |
| Optinose US, INC. | $396.02 | 2020-2025 | |
| Medtronic, INC. | $351.46 | 2024-2025 | Pteye Parathyroid Detection System, Fusion, Propel |
| Intersect Ent, INC. | $286.25 | 2019 | |
| Integra Lifesciences Corporation | $163.83 | 2024-2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Medtronic USA, INC. | $124.94 | 2019 | |
| Aerin Medical INC. | $123.14 | 2022-2025 | |
| Genzyme Corporation | $119.26 | 2019-2025 | |
| Cochlear Americas | $77.04 | 2019-2024 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Neurent Medical Limited | $74.45 | 2024 | Neuromark Radiofrequency Console, Neuromark Device |
| Glaxosmithkline, LLC. | $60.19 | 2024-2025 | Nucala |
| Ars Pharmaceuticals Operations, INC. | $55.94 | 2025 | Neffy |
| Hologic Sales and Service, LLC | $44.26 | 2023 | Coolseal Generator |
| Regeneron Healthcare Solutions, INC. | $39.86 | 2023-2024 | Dupixent |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $33.15 | 2019 | |
| Hikma Pharmaceuticals USA | $28.66 | 2024-2025 | Ryaltris |
| Photonicare INC | $27.21 | 2024 | Otosight Middle Ear Scope |
| Organogenesis INC. | $24.59 | 2025 | Via Matrix |
| Paratek Pharmaceuticals, INC. | $16.71 | 2025 | Xhance |
| Boston Scientific Corporation | $13.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Kelley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.